Growth Hormone News and Research RSS Feed - Growth Hormone News and Research

Growth hormone (GH) is a protein-based peptide hormone. It stimulates growth, cell reproduction and regeneration in humans and other animals. Growth hormone is a 191-amino acid, single-chain polypeptide that is synthesized, stored, and secreted by the somatotroph cells within the lateral wings of the anterior pituitary gland.
Some WADA-banned substances may have potential medical applications

Some WADA-banned substances may have potential medical applications

As the world awaits the start of the 2016 Summer Olympics, doping in athletes remains a hot topic. [More]
MIT researchers develop portable device to manufacture biopharmaceuticals on demand

MIT researchers develop portable device to manufacture biopharmaceuticals on demand

For medics on the battlefield and doctors in remote or developing parts of the world, getting rapid access to the drugs needed to treat patients can be challenging. [More]
Lifting lighter weights many times can be effective alternative way to gain muscle strength

Lifting lighter weights many times can be effective alternative way to gain muscle strength

New research from McMaster University is challenging traditional workout wisdom, suggesting that lifting lighter weights many times is as efficient as lifting heavy weights for fewer repetitions. [More]
Adjunct therapy with human growth hormone in IVF shows no apparent benefit in women

Adjunct therapy with human growth hormone in IVF shows no apparent benefit in women

Despite its occasional use as an adjunct in IVF, human growth hormone appears of little benefit to women having difficulty conceiving. [More]
New, simpler way for encapsulation-free controlled protein release

New, simpler way for encapsulation-free controlled protein release

A U of T Engineering team has designed a simpler way to keep therapeutic proteins where they are needed for long periods of time. The discovery is a potential game-changer for the treatment of chronic illnesses or injuries that often require multiple injections or daily pills. [More]
Researchers find way to selectively deliver drugs to placenta without harming fetus

Researchers find way to selectively deliver drugs to placenta without harming fetus

Nearly 10 percent of babies born in the United States are born premature, according to the March of Dimes. The underlying cause of many complications during pregnancy is often a poorly functioning placenta, the organ that nourishes and maintains the fetus. [More]
Combining aromatase inhibitors with growth hormone may help short adolescent boys grow taller

Combining aromatase inhibitors with growth hormone may help short adolescent boys grow taller

Aromatase inhibitors, when used for up to three years in combination with growth hormone, may effectively and safely help very short adolescent boys grow taller, new research suggests. The study results will be presented Sunday, April 3, at ENDO 2016, the annual meeting of the Endocrine Society in Boston. [More]
Researchers clarify potential transmissibility of Alzheimer's disease

Researchers clarify potential transmissibility of Alzheimer's disease

MedUni Vienna researchers have published the results of a clarifying research study on the potential transmissibility of Alzheimer's disease. Although the protein associated with Alzheimer's disease, amyloid-β, might be transmissible under very unusual circumstances, this does not go along with a transmission of the clinical manifestation of Alzheimer's disease. The affected persons develop no clinical symptoms of the disease. [More]
RUVICA (ibrutinib) capsules approved for treatment-naïve CLL patients

RUVICA (ibrutinib) capsules approved for treatment-naïve CLL patients

The U.S. Food and Drug Administration has approved IMBRUVICA (ibrutinib) capsules for treatment-naïve patients with chronic lymphocytic leukemia (CLL). [More]
Intestinal microbiota necessary for optimum postnatal growth

Intestinal microbiota necessary for optimum postnatal growth

The intestinal microbiota is necessary to ensure optimum postnatal growth and contributes to determining the size of adult individuals, notably in the event of undernutrition. [More]
Favourable safety, disease control for proton radiotherapy in paediatric medulloblastoma

Favourable safety, disease control for proton radiotherapy in paediatric medulloblastoma

Proton radiotherapy has an acceptable safety and disease control profile in paediatric medulloblastoma patients, according to research published in The Lancet Oncology. [More]
Study provides new insight into complex interchange that can raise blood levels of fat in type 1 diabetes

Study provides new insight into complex interchange that can raise blood levels of fat in type 1 diabetes

Researchers have new insight into the complex interchange that can raise blood levels of unhealthy lipids, or fat, in type 1 diabetes, and early evidence that a drug under study to block cancer cell growth can restore healthier levels. [More]
Proton beam therapy safe for treating childhood brain cancer medulloblastoma

Proton beam therapy safe for treating childhood brain cancer medulloblastoma

Proton beam therapy--a more precise form of radiotherapy--to treat the childhood brain cancer medulloblastoma appears to be as safe as conventional radiotherapy with similar survival rates, according to new research published in The Lancet Oncology journal today. [More]
Study focuses on parents' perceptions of risks, benefits of treating children with short stature

Study focuses on parents' perceptions of risks, benefits of treating children with short stature

A new study led by pediatric endocrinologist Adda Grimberg, M.D., of The Children's Hospital of Philadelphia, proposes to reframe the debate. "We set out to answer a new question," said Grimberg. "What are the factors, perceived or real, that drive some families to seek medical care for short stature?" [More]
Rotation model provides explanation of ligand activation mechanism of dimeric receptors

Rotation model provides explanation of ligand activation mechanism of dimeric receptors

"This 'rotation model', which made the cover of BioEssays, represents a true paradigm shift in the membrane receptor field," stated Prof. Pierre De Meyts, a renowned researcher of insulin and receptor binding for almost half a century and one of the reviewers of the paper by Prof. Ichiro Maruyama, the head of the Information Processing Biology Unit at Okinawa Institute of Science and Technology Graduate University. [More]
Latitude, summer daylight exposure make difference in results for children treated with growth hormone

Latitude, summer daylight exposure make difference in results for children treated with growth hormone

The rate of growth in children varies with the season while higher latitude and greater summer daylight exposure makes a significant difference in results for children treated with growth hormone, according to new research from The University of Manchester. [More]
Frost & Sullivan honours recipients of 2015 Excellence in Best Practices Awards

Frost & Sullivan honours recipients of 2015 Excellence in Best Practices Awards

On Thursday, October 22, Frost & Sullivan honoured recipients of its 2015 Excellence in Best Practices Awards Banquet in Monaco. With a festive ambiance and exciting Awards, the event brought together top executives to celebrate their success. [More]
Paradigm failure is primary reason for lack of progress in cancer research, says cancer biologist

Paradigm failure is primary reason for lack of progress in cancer research, says cancer biologist

A recent publication, which received sustained media attention, claimed that most cancers are just “bad luck”. Its authors stated that only about one-third of cancer mutations are caused by known lifestyle or environmental factors. [More]
No lasting metabolic health costs from combined GH and GnRH analogue therapy

No lasting metabolic health costs from combined GH and GnRH analogue therapy

Gonadotropin-releasing hormone analogue given alongside growth hormone during puberty in order to increase adult height does not have long-term metabolic health consequences in children born small for gestational age, research shows. [More]
Neuroendocrine sequelae common after paediatric optic gliomas

Neuroendocrine sequelae common after paediatric optic gliomas

Neuroendocrine sequelae are common following paediatric low-grade gliomas affecting the optic pathway, hypothalamus and suprasellar areas and are influenced by tumour location and treatment choice, a study shows. [More]
Advertisement
Advertisement